Fierce Biotech1 min read
saveVaccine biotech Evaxion halts infectious disease, autoimmune work to focus on oncology
Evaxion is refocusing its R&D efforts to solely focus on developing and advancing its cancer vaccines.
Evaxion is refocusing its R&D efforts to solely focus on developing and advancing its cancer vaccines.
comments(0)
5-min edit window · permanent after that